What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
The scientist’s investigation covers issues in Genetics, Genome-wide association study, Case-control study, Internal medicine and Pancreatic cancer.
His Genetics research focuses on Lung cancer and how it connects with Lung cancer susceptibility.
His Genome-wide association study study combines topics in areas such as Odds ratio, Polymorphism, Han chinese and Genetic predisposition.
In his research, KRAS is intimately related to Epidemiology of cancer, which falls under the overarching field of Case-control study.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology.
His Pancreatic cancer research includes elements of Endocrinology, Ubiquitin ligase, Prospective cohort study and Cancer research.
His most cited work include:
- Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. (413 citations)
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development (333 citations)
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development (333 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Genome-wide association study, Oncology, Genetics and Single-nucleotide polymorphism.
His research links Genotype with Internal medicine.
Chen Wu interconnects Carcinoma, Case-control study, Genetic association and Genetic predisposition in the investigation of issues within Genome-wide association study.
Chen Wu combines subjects such as Chemotherapy, Pancreatic cancer, Bioinformatics and Hazard ratio, Confidence interval with his study of Oncology.
His research investigates the connection between Pancreatic cancer and topics such as Prospective cohort study that intersect with problems in Endocrinology.
His Single-nucleotide polymorphism research incorporates elements of Genetic variation, Allele and Untranslated region.
He most often published in these fields:
- Internal medicine (44.97%)
- Genome-wide association study (37.87%)
- Oncology (32.54%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (31.36%)
- Internal medicine (44.97%)
- Cell (10.65%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Internal medicine, Cell, Carcinoma and Lung cancer.
His Cancer research research is multidisciplinary, relying on both Metformin, Protein kinase B, Pancreatic cancer and Cell growth.
The Internal medicine study combines topics in areas such as Endocrinology, Oncology and Cardiology.
His work in Carcinoma addresses subjects such as Kinase, which are connected to disciplines such as Apoptosis Regulator and Immunohistochemistry.
The study incorporates disciplines such as Meta-analysis, Prospective cohort study and Genome-wide association study in addition to Lung cancer.
As part of one scientific family, Chen Wu deals mainly with the area of Genome-wide association study, narrowing it down to issues related to the Genetic predisposition, and often Adenocarcinoma, Confidence interval, Mendelian randomization and Risk factor.
Between 2018 and 2021, his most popular works were:
- Excessive miR-25-3p maturation via N 6 -methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression (66 citations)
- Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. (22 citations)
- Single-cell transcriptomic analysis in a mouse model deciphers cell transition states in the multistep development of esophageal cancer. (5 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary areas of investigation include Cancer research, Cell, Downregulation and upregulation, Internal medicine and Oncology.
His Cancer research research integrates issues from Phenotype, Pleckstrin homology domain, Protein kinase B and Pancreatic cancer.
Chen Wu combines subjects such as Germline mutation, Genome-wide association study and Copy-number variation with his study of Internal medicine.
His study in Genome-wide association study is interdisciplinary in nature, drawing from both Mendelian randomization, Genetic predisposition, Lung, Cohort and Risk factor.
His studies in Oncology integrate themes in fields like Logistic regression, Cancer cell, Somatic evolution in cancer, KRAS and Exome.
The various areas that Chen Wu examines in his Lung cancer study include Meta-analysis, Proportional hazards model, Hazard ratio, Tuberculosis and Adenocarcinoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
